Screening and Identifying Hepatobiliary Diseases Via Deep Learning Using Ocular Images

August 16, 2020 updated by: Haotian Lin, Sun Yat-sen University
Artificial Intelligence may provide insight into exploring the potential covert association behind and reveal some early ocular architecture changes in individuals with hepatobiliary disorders. We conducted a pioneer work to explore the association between the eye and liver via deep learning, to develop and evaluate different deep learning models to predict the hepatobiliary disease by using ocular images.

Study Overview

Study Type

Observational

Enrollment (Actual)

1789

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Slit-lamp and retinal fundus images collected from Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Affiliated Huadu Hospital of Southern Medical University, Nantian Medical Centre of Aikang Health Care, and Huanshidong Medical Centre of Aikang Health Care.

Description

Inclusion Criteria:

  • The quality of fundus and slit-lamp images should clinical acceptable.
  • More than 90% of the fundus image area including four main regions (optic disk, macular, upper and lower retinal vessel archs) are easy to read and discriminate.
  • More than 90% of the slit-lamp image area including three main regions (sclera, pupil, and lens) are easy to read and discriminate.

Exclusion Criteria:

  • Images with light leakage (>10% of the area), spots from lens flares or stains, and overexposure were excluded from further analysis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
development dataset 01
Slit-lamp and retinal fundus images collected from Department of Hepatobiliary Surgery of the Third Affiliated Hospital of Sun Yat-sen University.
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
development dataset 02
Slit-lamp and retinal fundus images collected from Affiliated Huadu Hospital of Southern Medical University.
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
development dataset 03
Slit-lamp and retinal fundus images collected from Nantian Medical Centre of Aikang Health Care.
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
test dataset 01
Slit-lamp and retinal fundus images collected from Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University.
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
test dataset 02
Slit-lamp and retinal fundus images collected from Huanshidong Medical Centre of Aikang Health Care.
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
area under the receiver operating characteristic curve of the deep learning system
Time Frame: baseline
The investigators will calculate the area under the receiver operating characteristic curve of deep learning system and compare this index between deep learning system and human doctors
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sensitivity and specificity of the deep learning system
Time Frame: baseline
The investigators will calculate the sensitivity and specifity of deep learning system and compare this index between deep learning system and human doctors
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2018

Primary Completion (ACTUAL)

January 31, 2020

Study Completion (ACTUAL)

January 31, 2020

Study Registration Dates

First Submitted

December 25, 2019

First Submitted That Met QC Criteria

December 25, 2019

First Posted (ACTUAL)

December 30, 2019

Study Record Updates

Last Update Posted (ACTUAL)

August 18, 2020

Last Update Submitted That Met QC Criteria

August 16, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AEHD-2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Artificial Intelligence

Clinical Trials on Hepatobiliary Disorders

Subscribe